and Personalisation
of care for



Hypercholesterolemia :
it’s all about genes



Cardiovascular disease:
the number one cause
of death in France



Lowering LDL cholesterol
reduces the risk of cardiovascular events


Today in France, 1 person in every 300 suffers
from inherited hypercholesterolemia


The CHOPIN translational research project seeks to reduce cardiovascular risks
in patients by offering new personalised hypercholesterolemia treatment
 through the identification of new risk markers and therapeutic targets.

Academic and Industry partners

Clinical trials over 5 years

Patients involved

million euros obtained via the RHU call for projects